LIVER TRANSPLANTATION IN POSITIVE CYTOTOXIC CROSSMATCH CASES USING FK506, HIGH-DOSE STEROIDS, AND PROSTAGLANDIN E(1)

Ítems similars

• Use of Prostaglandin E(1) in Crossmatch-Negative Liver Transplant Recipients Treated With FK 506
  per: Takaya, S., et al.
  Publicat: (1993)
• Positive Crossmatch in Primary Human Liver Allografts Under Cyclosporine or FK 506 Therapy
  per: Takaya, S., et al.
  Publicat: (1991)
• THE ADVERSE IMPACT ON LIVER TRANSPLANTATION OF USING POSITIVE CYTOTOXIC CROSSMATCH DONORS
  per: Takaya, Shunichi, et al.
  Publicat: (1992)
• Correlation of Rejection Episodes With FK 506 Dosage, FK 506 Level, and Steroids Following Primary Orthotopic Liver Transplant
  per: Jain, A.B., et al.
  Publicat: (1991)
• Kidney Transplantation Under FK 506
  per: Starzl, Thomas E., et al.
  Publicat: (1990)